NAD Augmentation in Diabetes Kidney Disease

NCT05759468 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Type2diabetes
Diabetic Kidney Disease

Interventions

DRUG: Investigational Product - MIB 626
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]